Why the study?
The usefulness of ABI for predicting CV outcomes is limited in patients with normal ABI, while the prognostic value of UTCC in this population was unknown.
Does upstroke time per cardiac cycle (UTCC) predict cardiovascular and all-cause mortality better than ABI, baPWV, and LVEF in patients with normal ABI?
Does upstroke time per cardiac cycle (UTCC) predict cardiovascular and all-cause mortality better than ABI, baPWV, and LVEF in patients with normal ABI?
UTCC is a simple and novel parameter that independently predicts cardiovascular and all-cause mortality in patients with normal ABI, offering better additive predictive value than ABI and LVEF.
Answers are grounded in this paper and cite their sources.
UTCC may refine CV risk prediction in normal-ABI patients; leaves open whether it adds value beyond LVEF or baPWV in prospective cohorts.
AIM: Abnormal ankle-brachial index (ABI) is regarded as peripheral artery disease and can be used to predict cardiovascular (CV) outcomes. However, the usefulness of ABI for the prediction of CV outcome in patients with normal ABI is limited. Upstroke time per cardiac cycle (UTCC) is recently reported to be associated with mortality in patients with acute myocardial infarction and the elderly. Therefore, we aimed to evaluate UTCC, left ventricular ejection fraction (LVEF), brachial-ankle pulse wave velocity (baPWV), and ABI for the prediction of mortality in patients with normal ABI. METHODS: Patients arranged for echocardiographic examinations were enrolled, and 1076 patients with normal ABI were included. ABI, baPWV, and UTCC were measured by an ABI-form device. RESULTS: The median follow-up to mortality was 95 months. There were 88 CV and 244 all-cause deaths. After multivariate analysis, UTCC was associated with increased CV and all-cause mortality (P ≤ 0.004). Age, diabetes, heart failure, left ventricular hypertrophy, baPWV, and LVEF were also independent predictors of CV and all-cause mortality, but ABI was not. Furthermore, UTCC had a better additive predictive value than ABI, baPWV, and LVEF for CV mortality ( P ≤ 0.012). It also had a better additive predictive value than ABI and LVEF for all-cause mortality (P ≤ 0.013). CONCLUSIONS: UTCC is an independent predictor for CV and all-cause mortality in patients with normal ABI. It also has a better additive predictive value of CV and all-cause mortality than ABI and LVEF. Therefore, UTCC is a simple, novel, and useful parameter for identifying high-risk patients with normal ABI.
No takes yet. Share an insight, caveat, or question.
Su et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: